UroGen Pharma Ltd. reports insider transaction
- Chris Degnan, CFO, sold 2,202 shares on 10/08/2026
- Chris Degnan acquired 4,483 shares on 10/08/2026
- Shares sold at $36.69 per share
Chris Degnan, reporting
URGN
UroGen Pharma Ltd. SEC filings
Every EDGAR filing for UroGen Pharma Ltd. (URGN), newest first, with AI summaries and stories.
- Ticker
- URGN
- CIK
- 1668243
- Latest filing
- Oct 9
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4UroGen Pharma Ltd.URGNLIVE ROUTINE144UroGen Pharma Ltd.URGNLIVE UroGen Pharma Ltd. shares sold by Degnan Chris
- Form 144 filed on 2026-10-09
- 2202 shares to be sold
- Sold to cover tax withholding
Chris Degnan, reporting
ROUTINE4UroGen Pharma Ltd.URGNLIVE 2 insider filings
Mark Schoenberg, insider filing for URGN
Show all 2
- 4Insider filing for URGN
- 4Insider filing for URGN
Mark Schoenberg, reporting
ROUTINE144UroGen Pharma Ltd.URGNLIVE 2 Form 144 notices
Mark Schoenberg, planned sale of URGN shares
Show all 2
- 144Planned insider sale of URGN shares
- 144Planned insider sale of URGN shares
Mark Schoenberg, reporting
ROUTINE4UroGen Pharma Ltd.URGNLIVE James A. Robinson Jr., insider filing for URGN
James A. Robinson Jr., reporting
ROUTINE4UroGen Pharma Ltd.URGNLIVE Mark Schoenberg, insider filing for URGN
Mark Schoenberg, reporting
ROUTINE144UroGen Pharma Ltd.URGNLIVE Mark Schoenberg, planned sale of URGN shares
Mark Schoenberg, reporting
ROUTINE8-KUroGen Pharma Ltd.URGNLIVE ROUTINESCHEDULE 13G/AUroGen Pharma Ltd.URGNLIVE Ownership stake disclosure by TORONTO DOMINION BANK (amended)
TORONTO DOMINION BANK, filed by
ROUTINE8-KUroGen Pharma Ltd.URGNLIVE NOTABLE10-QUroGen Pharma Ltd.URGNLIVE ROUTINE4UroGen Pharma Ltd.URGNLIVE Mark Schoenberg, insider filing for URGN
Mark Schoenberg, reporting
ROUTINE144UroGen Pharma Ltd.URGNLIVE Mark Schoenberg, planned sale of URGN shares
Mark Schoenberg, reporting
ROUTINE4UroGen Pharma Ltd.URGNLIVE 7 insider filings
Mark Schoenberg, insider filing for URGN
Show all 7
- 4Insider filing for URGN
- 4Insider filing for URGN
- 4Insider filing for URGN
- 4Insider filing for URGN
- 4Insider filing for URGN
- 4Insider filing for URGN
- 4Insider filing for URGN
Mark Schoenberg, reporting
ROUTINE8-KUroGen Pharma Ltd.URGNLIVE ROUTINE144UroGen Pharma Ltd.URGNLIVE Mark Schoenberg, planned sale of URGN shares
Mark Schoenberg, reporting
ROUTINE4UroGen Pharma Ltd.URGNLIVE Mark Schoenberg, insider filing for URGN
Mark Schoenberg, reporting
ROUTINE144UroGen Pharma Ltd.URGNLIVE Mark Schoenberg, planned sale of URGN shares
Mark Schoenberg, reporting
ROUTINE8-KUroGen Pharma Ltd.URGNLIVE ROUTINEARSUroGen Pharma Ltd.URGNLIVE ROUTINE4UroGen Pharma Ltd.URGNLIVE James A. Robinson Jr., insider filing for URGN
James A. Robinson Jr., reporting
ROUTINESCHEDULE 13G/AUroGen Pharma Ltd.URGNLIVE Ownership stake disclosure by Paradigm Biocapital Advisors LP (amended)
Paradigm Biocapital Advisors LP, filed by
ROUTINESCHEDULE 13GUroGen Pharma Ltd.URGNLIVE Ownership stake disclosure by TORONTO DOMINION BANK
TORONTO DOMINION BANK, filed by
ROUTINE4UroGen Pharma Ltd.URGNLIVE Mark Schoenberg, insider filing for URGN
Mark Schoenberg, reporting
ROUTINE144UroGen Pharma Ltd.URGNLIVE Mark Schoenberg, planned sale of URGN shares
Mark Schoenberg, reporting
NOTABLE10-QUroGen Pharma Ltd.URGNLIVE ROUTINE8-KUroGen Pharma Ltd.URGNLIVE ROUTINEDEF 14AUroGen Pharma Ltd.URGNLIVE ROUTINESCHEDULE 13GUroGen Pharma Ltd.URGNLIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
ROUTINEPRE 14AUroGen Pharma Ltd.URGNLIVE NOTABLE10-KUroGen Pharma Ltd.URGNLIVE ROUTINE8-KUroGen Pharma Ltd.URGNLIVE ROUTINE8-KUroGen Pharma Ltd.URGNLIVE ROUTINE4UroGen Pharma Ltd.URGNLIVE James A. Robinson Jr., insider filing for URGN
James A. Robinson Jr., reporting
ROUTINE4UroGen Pharma Ltd.URGNLIVE Elizabeth A. Barrett, insider filing for URGN
Elizabeth A. Barrett, reporting
ROUTINESCHEDULE 13G/AUroGen Pharma Ltd.URGNLIVE Ownership stake disclosure by TORONTO DOMINION BANK (amended)
TORONTO DOMINION BANK, filed by
ROUTINE4UroGen Pharma Ltd.URGNLIVE Jason Drew Smith, insider filing for URGN
Jason Drew Smith, reporting
ROUTINE4UroGen Pharma Ltd.URGNLIVE Mark Schoenberg, insider filing for URGN
Mark Schoenberg, reporting
ROUTINE4UroGen Pharma Ltd.URGNLIVE 2 insider filings
Mark Schoenberg, insider filing for URGN
Show all 2
- 4Insider filing for URGN
- 4Insider filing for URGN
Mark Schoenberg, reporting
ROUTINE144UroGen Pharma Ltd.URGNLIVE Mark Schoenberg, planned sale of URGN shares
Mark Schoenberg, reporting
ROUTINE4UroGen Pharma Ltd.URGNLIVE Stuart Holden, insider filing for URGN
Stuart Holden, reporting